Intermittent melphalan therapy in multiple myeloma

JAMA. 1969 Jul 14;209(2):251-3.
No abstract available

MeSH terms

  • Blood Cell Count
  • Humans
  • Leukopenia / chemically induced
  • Melphalan / administration & dosage*
  • Melphalan / adverse effects
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Thrombocytopenia / chemically induced

Substances

  • Melphalan